These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3919531

  • 1. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.
    Groop L, Harno K, Nikkilä EA, Pelkonen R, Tolppanen EM.
    Acta Med Scand; 1985; 217(1):33-9. PubMed ID: 3919531
    [Abstract] [Full Text] [Related]

  • 2. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
    Kyllästinen M, Groop L.
    Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
    [Abstract] [Full Text] [Related]

  • 3. The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes.
    Groop L, Harno K, Tolppanen EM.
    Acta Endocrinol (Copenh); 1984 May; 106(1):97-101. PubMed ID: 6428120
    [Abstract] [Full Text] [Related]

  • 4. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.
    Falko JM, Osei K.
    Am J Med; 1985 Sep 20; 79(3B):92-101. PubMed ID: 3931467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.
    Groop L, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A.
    Diabetes Care; 1987 Sep 20; 10(6):671-8. PubMed ID: 3123184
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Combined treatment of type-2 diabetics with insulin and glibenclamide after secondary drug failure. Double-blind, insulin-placebo-controlled crossover study].
    Rosak C, Schwarz O, Althoff PH, Schöffling K, Schmidt FH.
    Dtsch Med Wochenschr; 1985 Dec 20; 110(51-52):1975-80. PubMed ID: 3935405
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy.
    Lins PE, Lundblad S, Persson-Trotzig E, Adamson U.
    Acta Med Scand; 1988 Dec 20; 223(2):171-9. PubMed ID: 3126626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term double-blind, placebo-controlled trial.
    Casner PR.
    Clin Pharmacol Ther; 1988 Nov 20; 44(5):594-603. PubMed ID: 3141099
    [Abstract] [Full Text] [Related]

  • 20. Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
    Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ.
    Diabetes Care; 1992 Aug 20; 15(8):953-9. PubMed ID: 1387073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.